| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Harvey Robert Klingensmith is Director at CLB. Harvey Robert Klingensmith's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $489K at current prices.
Harvey Robert Klingensmith has 3 Form 4 filings on record from April 2024 to April 2026, all as Director at Core Laboratories (CLB), 2024–2026.
The 6 reported transactions were 3 option exercises and 3 option or other derivative awards.
There are no priced open-market purchases or sales on record, so none of these filings shows a decision to buy or sell shares in the market.
No transactions found
Try adjusting your filters or search criteria